A non-heme IRON enzyme that catalyzes the conversion of MYOINOSITOL to D-glucuronic acid. The reaction is the first committed step in MYOINOSITOL catabolic pathway. This enzyme was formerly characterized as EC 1.13.1.11 and 1.99.2.6.
A mixed function oxidase enzyme which during hemoglobin catabolism catalyzes the degradation of heme to ferrous iron, carbon monoxide and biliverdin in the presence of molecular oxygen and reduced NADPH. The enzyme is induced by metals, particularly cobalt. EC 1.14.99.3.
An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
Phosphoric acid esters of inositol. They include mono- and polyphosphoric acid esters, with the exception of inositol hexaphosphate which is PHYTIC ACID.
Intracellular messenger formed by the action of phospholipase C on phosphatidylinositol 4,5-bisphosphate, which is one of the phospholipids that make up the cell membrane. Inositol 1,4,5-trisphosphate is released into the cytoplasm where it releases calcium ions from internal stores within the cell's endoplasmic reticulum. These calcium ions stimulate the activity of B kinase or calmodulin.
Intracellular receptors that bind to INOSITOL 1,4,5-TRISPHOSPHATE and play an important role in its intracellular signaling. Inositol 1,4,5-trisphosphate receptors are calcium channels that release CALCIUM in response to increased levels of inositol 1,4,5-trisphosphate in the CYTOPLASM.
A carboxy-lyase that plays a key role in photosynthetic carbon assimilation in the CALVIN-BENSON CYCLE by catalyzing the formation of 3-phosphoglycerate from ribulose 1,5-biphosphate and CARBON DIOXIDE. It can also utilize OXYGEN as a substrate to catalyze the synthesis of 2-phosphoglycolate and 3-phosphoglycerate in a process referred to as photorespiration.
'Sugar phosphates' are organic compounds that consist of a sugar molecule linked to one or more phosphate groups, playing crucial roles in biochemical processes such as energy transfer and nucleic acid metabolism.
Oxidases that specifically introduce DIOXYGEN-derived oxygen atoms into a variety of organic molecules.
A ubiquitous stress-responsive enzyme that catalyzes the oxidative cleavage of HEME to yield IRON; CARBON MONOXIDE; and BILIVERDIN.
A dioxygenase with specificity for the oxidation of the indoleamine ring of TRYPTOPHAN. It is a LIVER-specific enzyme that is the first and rate limiting enzyme in the kynurenine pathway of TRYPTOPHAN catabolism.
The profession of writing. Also the identity of the writer as the creator of a literary production.
Organic compounds containing the carboxy group (-COOH). This group of compounds includes amino acids and fatty acids. Carboxylic acids can be saturated, unsaturated, or aromatic.
Collections of facts, assumptions, beliefs, and heuristics that are used in combination with databases to achieve desired results, such as a diagnosis, an interpretation, or a solution to a problem (From McGraw Hill Dictionary of Scientific and Technical Terms, 6th ed).
The guidelines and policy statements set forth by the editor(s) or editorial board of a publication.
Intentional falsification of scientific data by presentation of fraudulent or incomplete or uncorroborated findings as scientific fact.
"The business or profession of the commercial production and issuance of literature" (Webster's 3d). It includes the publisher, publication processes, editing and editors. Production may be by conventional printing methods or by electronic publishing.
A class of amino acids characterized by a closed ring structure.

Identification of a novel kidney-specific gene downregulated in acute ischemic renal failure. (1/20)

To gain further insights into the molecular mechanisms involved in acute renal failure, we have isolated a new gene from rat and human, named KSP32 (kidney-specific protein with a molecular mass of 32 kDa). KSP32 encodes a novel gene that shows little homology to other mammalian proteins. It, however, shares extensive homology with several proteins found in the nematode Caenorhabditis elegans and plants. The expression of KSP32 mRNA is highly restricted to kidney. In situ hybidization analysis revealed that the expression of KSP32 mRNA was prominent in the boundary of kidney cortex and outer medulla, exhibiting a raylike formation extending from the medulla into the cortex. Finally, KSP32 mRNA was dramatically downregulated in rat following induction of acute ischemic renal failure. Rapid loss of KSP32 mRNA expression was observed beginning at approximately 5 h following renal injury and mRNA levels remained depressed for at least 96 h. Both KSP32 mRNA levels as well as renal function recovered 14 days after injury. Administration of an endothelin receptor antagonist (SB-209670), known to restore renal function, significantly increased KSP32 expression.  (+info)

myo-Inositol oxygenase: molecular cloning and expression of a unique enzyme that oxidizes myo-inositol and D-chiro-inositol. (2/20)

myo-Inositol oxygenase (MIOX) catalyses the first committed step in the only pathway of myo-inositol catabolism, which occurs predominantly in the kidney. The enzyme is a non-haem-iron enzyme that catalyses the ring cleavage of myo-inositol with the incorporation of a single atom of oxygen. A full-length cDNA was isolated from a pig kidney library with an open reading frame of 849 bp and a corresponding protein subunit molecular mass of 32.7 kDa. The cDNA was expressed in a bacterial pET expression system and an active recombinant MIOX was purified from bacterial lysates to electrophoretic homogeneity. The purified enzyme displayed the same catalytic properties as the native enzyme with K(m) and k(cat) values of 5.9 mM and 11 min(-1) respectively. The pI was estimated to be 4.5. Preincubation with 1 mM Fe(2+) and 2 mM cysteine was essential for the enzyme's activity. D-chiro-Inositol, a myo-inositol isomer, is a substrate for the recombinant MIOX with an estimated K(m) of 33.5 mM. Both myo-inositol and D-chiro-inositol have been implicated in the pathogenesis of diabetes. Thus an understanding of the regulation of MIOX expression clearly represents a potential window on the aetiology of diabetes as well as on the control of various intracellular phosphoinositides and key signalling pathways.  (+info)

myo-inositol oxygenase offers a possible entry point into plant ascorbate biosynthesis. (3/20)

Two biosynthetic pathways for ascorbate (l-ascorbic acid [AsA]; vitamin C) in plants are presently known, the mannose/l-galactose pathway and an l-GalUA pathway. Here, we present molecular and biochemical evidence for a possible biosynthetic route using myo-inositol (MI) as the initial substrate. A MI oxygenase (MIOX) gene was identified in chromosome 4 (miox4) of Arabidopsis ecotype Columbia, and its enzymatic activity was confirmed in bacterially expressed recombinant protein. Miox4 was primarily expressed in flowers and leaves of wild-type Arabidopsis plants, tissues with a high concentration of AsA. Ascorbate levels increased 2- to 3-fold in homozygous Arabidopsis lines overexpressing the miox4 open reading frame, thus suggesting the role of MI in AsA biosynthesis and the potential for using this gene for the agronomic and nutritional enhancement of crops.  (+info)

Up-regulation of human myo-inositol oxygenase by hyperosmotic stress in renal proximal tubular epithelial cells. (4/20)

myo-Inositol oxygenase (MIOX) catalyzes the oxidative cleavage of myo-inositol (MI) to give d-glucuronic acid, a committed step in MI catabolism. d-Glucuronic acid is further metabolized to xylitol via the glucuronate-xylulose pathway. Although accumulation of polyols such as xylitol and sorbitol is associated with MI depletion in diabetic complications, no causal relationship has been established. Therefore we are examining the role of MIOX in diabetic nephropathy. Here we present evidence that the basis for the depletion of MI in diabetes is likely to be mediated by the increased expression of MIOX, which is induced by sorbitol, mannitol, and xylitol in a porcine renal proximal tubular epithelial cell line, LLC-PK1. To understand the molecular mechanism of regulation of MIOX expression by polyols, we have cloned the human MIOX gene locus of 10 kb containing 5.6 kb of the 5' upstream sequence. Analysis of the 5' upstream sequence led to the identification of an osmotic response element (ORE) in the promoter region, which is present approximately 2 kb upstream of the translation start site. Based on luciferase reporter and electrophoretic mobility shift assays, polyols increased the ORE-dependent expression of MIOX. In addition, we demonstrate that the activity of the promoter is dependent on the binding of the transcription factor, tonicity element-binding protein, or osmotic response element-binding protein, to the ORE site. These results suggest that the expression of MIOX is up-regulated by a positive feedback mechanism where xylitol, one of the products of MI catabolism via the glucuronate-xylulose pathway, induces an overexpression of MIOX.  (+info)

Modulation of renal-specific oxidoreductase/myo-inositol oxygenase by high-glucose ambience. (5/20)

Biological properties of renal-specific oxidoreductase (RSOR), characteristics of its promoter, and underlying mechanisms regulating its expression in diabetes were analyzed. RSOR expression, normally confined to the renal cortex, was markedly increased and extended into the outer medullary tubules in db/db mice, a model of type 2 diabetes. Exposure of LLCPK cells to d-glucose resulted in a dose-dependent increase in RSOR expression and its enzymatic activity. The latter was related to one of the glycolytic enzymes, myo-inositol oxygenase. The increase in activity was in proportion to serum glucose concentration. The RSOR expression also increased in cells treated with various organic osmolytes, e.g., sorbitol, myoinositol, and glycerolphosphoryl-choline and H(2)O(2). Basal promoter activity was confined to -1,252 bp upstream of ATG, and it increased with the treatment of high glucose and osmolytes. EMSAs indicated an increased binding activity with osmotic-, carbohydrate-, and oxidant-response elements in cells treated with high glucose and was abolished by competitors. Supershifts, detected by anti-nuclear factor of activated T cells, and carbohydrate-response-element-binding protein established the binding specificity. Nuclear factor of activated T cells tonicity-enhancer-binding protein and carbohydrate-response-element-binding protein had increased nuclear expression in cells treated with high glucose. The activity of osmotic-response element exhibited a unique alternate binding pattern, as yet unreported in osmoregulatory genes. Data indicate that RSOR activity is modulated by diverse mechanisms, and it is endowed with dual properties to channel glucose intermediaries, characteristic of hepatic aldehyde reductases, and to maintain osmoregulation, a function of renal medullary genes, e.g., aldose reductase, in diabetes.  (+info)

Evidence for C-H cleavage by an iron-superoxide complex in the glycol cleavage reaction catalyzed by myo-inositol oxygenase. (6/20)

myo-Inositol oxygenase (MIOX) activates O2 at a mixed-valent nonheme diiron(II/III) cluster to effect oxidation of its cyclohexan-(1,2,3,4,5,6-hexa)-ol substrate [myo-inositol (MI)] by four electrons to d-glucuronate. Abstraction of hydrogen from C1 by a formally (superoxo)diiron(III/III) intermediate was previously proposed. Use of deuterium-labeled substrate, 1,2,3,4,5,6-[2H]6-MI (D6-MI), has now permitted initial characterization of the C-H-cleaving intermediate. The MIOX.1,2,3,4,5,6-[2H]6-MI complex reacts rapidly and reversibly with O2 to form an intermediate, G, with a g = (2.05, 1.98, 1.90) EPR signal. The rhombic g-tensor and observed hyperfine coupling to 57Fe are rationalized in terms of a (superoxo)diiron(III/III) structure with coordination of the superoxide to a single iron. G decays to H, the intermediate previously detected in the reaction with unlabeled substrate. This step is associated with a kinetic isotope effect of > or =5, showing that the superoxide-level complex does indeed cleave a C-H(D) bond of MI.  (+info)

Purification, crystallization and preliminary crystallographic analysis of mouse myo-inositol oxygenase. (7/20)

Myo-inositol oxygenase (MIOX) catalyzes the novel oxidative cleavage of myo-inositol (MI) and its epimer D-chiro inositol (DCI) to D-glucuronate. MIOX utilizes an Fe(II)/Fe(III) binuclear iron centre for the dioxygen-dependent cleavage of the C1-C6 bond in MI. Despite its key role in inositol metabolism, the structural basis of its unique four-electron oxidation mechanism and its substrate specificity remain unknown. In order to answer these questions and to facilitate the use of this key enzyme for the development of new therapeutic strategies for diabetes, the mouse enzyme has been cloned, expressed in Escherichia coli, purified and crystallized from 4.4 M sodium formate. The crystals belong to space group P2(1)2(1)2(1), with unit-cell parameters a = 44.87, b = 77.26, c = 84.84 angstroms, and diffract to 2.8 angstroms resolution.  (+info)

Crystal structure of a substrate complex of myo-inositol oxygenase, a di-iron oxygenase with a key role in inositol metabolism. (8/20)

Altered metabolism of the inositol sugars myo-inositol (MI) and d-chiro-inositol is implicated in diabetic complications. In animals, catabolism of MI and D-chiro-inositol depends on the enzyme MI oxygenase (MIOX), which catalyzes the first committed step of the glucuronate-xylulose pathway, and is found almost exclusively in the kidneys. The crystal structure of MIOX, in complex with MI, has been determined by multiwavelength anomalous diffraction methods and refined at 2.0-A resolution (R=0.206, Rfree=0.253). The structure reveals a monomeric, single-domain protein with a mostly helical fold that is distantly related to the diverse HD domain superfamily. Five helices form the structural core and provide six ligands (four His and two Asp) for the di-iron center, in which the two iron atoms are bridged by a putative hydroxide ion and one of the Asp ligands, Asp-124. A key loop forms a lid over the MI substrate, which is coordinated in bidentate mode to one iron atom. It is proposed that this mode of iron coordination, and interaction with a key Lys residue, activate MI for bond cleavage. The structure also reveals the basis of substrate specificity and suggests routes for the development of specific MIOX inhibitors.  (+info)

Inositol oxygenase is not a widely recognized medical term, but it does refer to an enzyme that is involved in certain biochemical reactions. Here is a general definition:

Inositol oxygenase (IO) is an enzyme that catalyzes the oxidation of myo-inositol to form D-glucuronic acid and S-d-glucuronosyl-L-serine, using molecular oxygen as a co-substrate. This reaction is part of the inositol metabolic pathway, which plays a role in various cellular processes such as signal transduction, lipid synthesis, and stress response. In humans, mutations in the IO gene have been associated with neurological disorders and developmental abnormalities.

Inositol is not considered a true "vitamin" because it can be created by the body from glucose. However, it is an important nutrient and is sometimes referred to as vitamin B8. It is a type of sugar alcohol that is found in both animals and plants. Inositol is involved in various biological processes, including:

1. Signal transduction: Inositol phospholipids are key components of cell membranes and play a crucial role in intracellular signaling pathways. They act as secondary messengers in response to hormones, neurotransmitters, and growth factors.
2. Insulin sensitivity: Inositol and its derivatives, such as myo-inositol and D-chiro-inositol, are involved in insulin signal transduction. Abnormalities in inositol metabolism have been linked to insulin resistance and conditions like polycystic ovary syndrome (PCOS).
3. Cerebral and ocular functions: Inositol is essential for the proper functioning of neurons and has been implicated in various neurological and psychiatric disorders, such as depression, anxiety, and bipolar disorder. It also plays a role in maintaining eye health.
4. Lipid metabolism: Inositol participates in the breakdown and transport of fats within the body.
5. Gene expression: Inositol and its derivatives are involved in regulating gene expression through epigenetic modifications.

Inositol can be found in various foods, including fruits, beans, grains, nuts, and vegetables. It is also available as a dietary supplement for those who wish to increase their intake.

Inositol phosphates are a family of molecules that consist of an inositol ring, which is a six-carbon heterocyclic compound, linked to one or more phosphate groups. These molecules play important roles as intracellular signaling intermediates and are involved in various cellular processes such as cell growth, differentiation, and metabolism.

Inositol hexakisphosphate (IP6), also known as phytic acid, is a form of inositol phosphate that is found in plant-based foods. IP6 has the ability to bind to minerals such as calcium, magnesium, and iron, which can reduce their bioavailability in the body.

Inositol phosphates have been implicated in several diseases, including cancer, diabetes, and neurodegenerative disorders. For example, altered levels of certain inositol phosphates have been observed in cancer cells, suggesting that they may play a role in tumor growth and progression. Additionally, mutations in enzymes involved in the metabolism of inositol phosphates have been associated with several genetic diseases.

Inositol 1,4,5-trisphosphate (IP3) is a intracellular signaling molecule that plays a crucial role in the release of calcium ions from the endoplasmic reticulum into the cytoplasm. It is a second messenger, which means it relays signals received by a cell's surface receptors to various effector proteins within the cell. IP3 is produced through the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) by activated phospholipase C (PLC) enzymes in response to extracellular signals such as hormones and neurotransmitters. The binding of IP3 to its receptor on the endoplasmic reticulum triggers the release of calcium ions, which then activates various cellular processes like gene expression, metabolism, and muscle contraction.

Inositol 1,4,5-trisphosphate receptors (IP3Rs) are a type of calcium ion channel found in the endoplasmic reticulum (ER) membrane of many cell types. They play a crucial role in intracellular calcium signaling and are activated by the second messenger molecule, inositol 1,4,5-trisphosphate (IP3).

IP3 is produced by enzymatic cleavage of the membrane lipid phosphatidylinositol 4,5-bisphosphate (PIP2) in response to extracellular signals such as hormones and neurotransmitters. When IP3 binds to the IP3R, it triggers a conformational change that opens the channel, allowing calcium ions to flow from the ER into the cytosol. This increase in cytosolic calcium can then activate various cellular processes such as gene expression, protein synthesis, and cell survival or death pathways.

There are three isoforms of IP3Rs (IP3R1, IP3R2, and IP3R3) that differ in their tissue distribution, regulation, and sensitivity to IP3. Dysregulation of IP3R-mediated calcium signaling has been implicated in various pathological conditions, including neurological disorders, cardiovascular diseases, and cancer.

Ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO) is a crucial enzyme in the Calvin cycle, which is a process that plants use to convert carbon dioxide into glucose during photosynthesis. RuBisCO catalyzes the reaction between ribulose-1,5-bisphosphate and carbon dioxide, resulting in the formation of two molecules of 3-phosphoglycerate, which can then be converted into glucose.

RuBisCO is considered to be the most abundant enzyme on Earth, making up as much as 50% of the soluble protein found in leaves. It is a large and complex enzyme, consisting of eight small subunits and eight large subunits that are arranged in a barrel-shaped structure. The active site of the enzyme, where the reaction between ribulose-1,5-bisphosphate and carbon dioxide takes place, is located at the interface between two large subunits.

RuBisCO also has a secondary function as an oxygenase, which can lead to the production of glycolate, a toxic compound for plants. This reaction occurs when the enzyme binds with oxygen instead of carbon dioxide and is more prevalent in environments with low carbon dioxide concentrations and high oxygen concentrations. The glycolate produced during this process needs to be recycled through a series of reactions known as photorespiration, which can result in significant energy loss for the plant.

Sugar phosphates are organic compounds that play crucial roles in various biological processes, particularly in the field of genetics and molecular biology. They are formed by the attachment of a phosphate group to a sugar molecule, most commonly to the 5-carbon sugar ribose or deoxyribose.

In genetics, sugar phosphates form the backbone of nucleic acids, such as DNA and RNA. In DNA, the sugar phosphate backbone consists of alternating deoxyribose (a sugar) and phosphate groups, linked together by covalent bonds between the 5' carbon atom of one sugar molecule and the 3' carbon atom of another sugar molecule. This forms a long, twisted ladder-like structure known as a double helix.

Similarly, in RNA, the sugar phosphate backbone is formed by ribose (a sugar) and phosphate groups, creating a single-stranded structure that can fold back on itself to form complex shapes. These sugar phosphate backbones provide structural support for the nucleic acids and help to protect the genetic information stored within them.

Sugar phosphates also play important roles in energy metabolism, as they are involved in the formation and breakdown of high-energy compounds such as ATP (adenosine triphosphate) and GTP (guanosine triphosphate). These molecules serve as energy currency for cells, storing and releasing energy as needed to power various cellular processes.

Oxygenases are a class of enzymes that catalyze the incorporation of molecular oxygen (O2) into their substrates. They play crucial roles in various biological processes, including the biosynthesis of many natural products, as well as the detoxification and degradation of xenobiotics (foreign substances).

There are two main types of oxygenases: monooxygenases and dioxygenases. Monooxygenases introduce one atom of molecular oxygen into a substrate while reducing the other to water. An example of this type of enzyme is cytochrome P450, which is involved in drug metabolism and steroid hormone synthesis. Dioxygenases, on the other hand, incorporate both atoms of molecular oxygen into their substrates, often leading to the formation of new carbon-carbon bonds or the cleavage of existing ones.

It's important to note that while oxygenases are essential for many life-sustaining processes, they can also contribute to the production of harmful reactive oxygen species (ROS) during normal cellular metabolism. An imbalance in ROS levels can lead to oxidative stress and damage to cells and tissues, which has been linked to various diseases such as cancer, neurodegeneration, and cardiovascular disease.

Heme Oxygenase-1 (HO-1) is an inducible enzyme that catalyzes the degradation of heme into biliverdin, iron, and carbon monoxide. It is a rate-limiting enzyme in the oxidative degradation of heme. HO-1 is known to play a crucial role in cellular defense against oxidative stress and inflammation. It is primarily located in the microsomes of many tissues, including the spleen, liver, and brain. Induction of HO-1 has been shown to have cytoprotective effects, while deficiency in HO-1 has been associated with several pathological conditions, such as vascular diseases, neurodegenerative disorders, and cancer.

Tryptophan oxygenase, also known as tryptophan 2,3-dioxygenase (TDO) or tryptophan pyrrolase, is an enzyme that catalyzes the breakdown of the essential amino acid tryptophan. This enzyme requires molecular oxygen and plays a crucial role in regulating tryptophan levels within the body.

The reaction catalyzed by tryptophan oxygenase involves the oxidation of the indole ring of tryptophan, leading to the formation of N-formylkynurenine. This metabolite is further broken down through several enzymatic steps to produce other biologically active compounds, such as kynurenine and niacin (vitamin B3).

Tryptophan oxygenase activity is primarily found in the liver and is induced by various factors, including corticosteroids, cytokines, and tryptophan itself. The regulation of this enzyme has implications for several physiological processes, such as immune response, neurotransmitter synthesis, and energy metabolism. Dysregulation of tryptophan oxygenase activity can contribute to the development of various pathological conditions, including neurological disorders and cancer.

In the context of medical research, authorship refers to the recognition of individuals who have made significant contributions to the development and completion of a scientific paper or research project. The International Committee of Medical Journal Editors (ICMJE) has established guidelines for determining authorship, which include the following four criteria:

1. Substantial contribution to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work.
2. Drafting the work or revising it critically for important intellectual content.
3. Final approval of the version to be published.
4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

All authors should meet these criteria, and their contributions should be clearly described in the manuscript. It is important to note that authorship should not be granted based on position or status alone, but rather on the basis of substantial intellectual contribution and commitment to the work.

Carboxylic acids are organic compounds that contain a carboxyl group, which is a functional group made up of a carbon atom doubly bonded to an oxygen atom and single bonded to a hydroxyl group. The general formula for a carboxylic acid is R-COOH, where R represents the rest of the molecule.

Carboxylic acids can be found in various natural sources such as in fruits, vegetables, and animal products. Some common examples of carboxylic acids include formic acid (HCOOH), acetic acid (CH3COOH), propionic acid (C2H5COOH), and butyric acid (C3H7COOH).

Carboxylic acids have a variety of uses in industry, including as food additives, pharmaceuticals, and industrial chemicals. They are also important intermediates in the synthesis of other organic compounds. In the body, carboxylic acids play important roles in metabolism and energy production.

I'm sorry for any confusion, but "knowledge bases" is a general term that refers to structured collections of knowledge in a specific field or area, and it is not a medical term with a defined meaning in the medical field. Knowledge bases can be found in many fields, including medicine, and they typically take the form of databases or repositories of information that are used to store, organize, and retrieve knowledge. In the medical field, knowledge bases might include information about diseases, treatments, medications, and other medical topics. They can be used by healthcare professionals, researchers, and patients to access accurate and reliable information.

Editorial policies refer to a set of guidelines and principles that govern the development, selection, peer-review, production, and publication of manuscripts in a medical journal. These policies aim to ensure the integrity, transparency, and quality of the published research while adhering to ethical standards and best practices in scientific publishing.

Some essential components of editorial policies include:

1. Authorship criteria: Defining who qualifies as an author, their roles, and responsibilities, and specifying the order of authorship based on contribution.
2. Conflict of interest disclosure: Requiring authors, reviewers, and editors to declare any potential conflicts of interest that may influence their judgment or objectivity in the manuscript's evaluation.
3. Peer-review process: Outlining the steps involved in the peer-review process, including the selection of reviewers, the number of required reviews, and the criteria for accepting or rejecting a manuscript.
4. Plagiarism detection: Employing plagiarism detection software to ensure originality and prevent unethical practices such as self-plagiarism or duplicate publication.
5. Data sharing: Encouraging or requiring authors to share their data, code, or materials to promote transparency and reproducibility of the research findings.
6. Corrections and retractions: Establishing procedures for correcting errors, addressing scientific misconduct, and retracting published articles when necessary.
7. Post-publication discussions: Encouraging open dialogue and constructive criticism through post-publication discussions or letters to the editor.
8. Accessibility and copyright: Describing how the journal ensures accessibility of its content, such as through open-access models, and outlining the terms of copyright and licensing agreements.
9. Archiving and preservation: Ensuring long-term preservation and availability of published content by depositing it in appropriate digital archives or repositories.
10. Compliance with international standards: Adhering to guidelines and best practices established by organizations such as the International Committee of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), and the Committee on Publication Ethics (COPE).

Scientific misconduct is defined by the US Department of Health and Human Services as "fabrication, falsification, or plagiarism in proposing, performing, or reviewing research, or in reporting research results." Fabrication means making up data or results that never occurred. Falsification means manipulating research materials, equipment, or processes, or changing or omitting data or results such that the research is not accurately represented in the research record. Plagiarism is the appropriation of another person's ideas, processes, results, or words without giving appropriate credit.

Scientific misconduct also includes other practices that seriously deviate from those that are commonly accepted within the scientific community for proposing, conducting, or reporting research. It does not include honest error or differences of opinion.

It is important to note that scientific misconduct can have serious consequences for the individuals involved and for the integrity of the scientific enterprise as a whole. It is essential that researchers adhere to the highest standards of integrity in order to maintain public trust in science and to ensure that research results are reliable and reproducible.

I'm sorry for any confusion, but "publishing" is not a term that has a medical definition. Publishing typically refers to the process of preparing and disseminating information, such as books, journals, or articles, to the public or a specific audience. It could involve both print and digital media. If you have any questions related to medicine or healthcare, I'd be happy to try to help answer those!

Cyclic amino acids are a type of modified amino acid where the side chain of the amino acid forms a ring structure. This is different from the typical structure of amino acids, which have a linear side chain. The formation of the ring can occur within the same amino acid molecule or between two amino acid molecules.

Cyclic amino acids play important roles in various biological processes. For example, some cyclic amino acids are involved in the structure and function of proteins, while others serve as signaling molecules or neurotransmitters. Some common examples of cyclic amino acids include proline, hydroxyproline, and sarcosine.

It is worth noting that not all modified amino acids with ring structures are considered cyclic amino acids. For example, some amino acids may have a sulfur atom in their side chain that forms a disulfide bond with another cysteine residue, but this is not considered a cyclic structure because the ring is formed between two separate molecules rather than within a single molecule.

... , also commonly referred to as myo-inositol oxygenase (MIOX), is a non-heme di-iron enzyme that oxidizes myo- ... Inositol Glucuronic acid Oxygenases Bollinger JM, Diao Y, Matthews ML, Xing G, Krebs C (February 2009). "myo-Inositol oxygenase ... "myo-Inositol oxygenase: molecular cloning and expression of a unique enzyme that oxidizes myo-inositol and D-chiro-inositol". ... "Crystal structure of a substrate complex of myo-inositol oxygenase, a di-iron oxygenase with a key role in inositol metabolism ...
Elevating vitamin C content by overexpressing inositol oxygenase and gulono-1,4-lactone oxidase in A. thaliana leads to ...
... inositol oxygenase MeSH D12.776.556.579.374.375 - iron-sulfur proteins MeSH D12.776.556.579.374.375.025 - adrenodoxin MeSH ...
... tryptophan oxygenase MeSH D08.811.682.690.562 - inositol oxygenase MeSH D08.811.682.690.708 - mixed function oxygenases MeSH ... heme oxygenase (decyclizing) MeSH D08.811.682.690.708.410.500 - heme oxygenase-1 MeSH D08.811.682.690.708.425 - 4- ... myo-inositol-1-phosphate synthase MeSH D08.811.399.475.200 - aldose-ketose isomerases MeSH D08.811.399.475.200.174 - autocrine ... CDP-diacylglycerol-inositol 3-phosphatidyltransferase MeSH D08.811.913.696.900.150 - CDP-diacylglycerol-serine O- ...
... inositol oxygenase EC 1.13.99.2: Now EC 1.14.12.10, benzoate 1,2-dioxygenase EC 1.13.99.3: tryptophan 2′-dioxygenase EC 1.13. ... D-chiro-inositol 1-dehydrogenase EC 1.1.1.370: scyllo-inositol 2-dehydrogenase (NAD+) EC 1.1.1.371: scyllo-inositol 2- ... inositol oxygenase Portal: Biology "ExplorEnz - The Enzyme Database". McDonald, A.G.; Boyce, S.; K.F., Tipton (2009). " ... heme oxygenase (mycobilin-producing) EC 1.14.99.58: heme oxygenase (biliverdin-IX-β and δ-forming) EC 1.14.99.59: tryptamine 4- ...
The other ADP-receptor P2Y1 couples to Gq that activates phospholipase C-beta 2 (PLCB2), resulting in inositol 1,4,5- ... cyclo-oxygenase 1, and thromboxane-A synthase. Platelets secrete thromboxane A2, which acts on the platelet's own thromboxane ...
1996). "Involvement of p72syk kinase, p53/56lyn kinase and phosphatidyl inositol-3 kinase in signal transduction via the human ... 2007). "SREBP-1 regulates the expression of heme oxygenase 1 and the phosphatidylinositol-3 kinase regulatory subunit p55 gamma ...
The inositol-requiring enzyme-1 (IRE1) and protein kinase RNA-like endoplasmic reticulum kinase (PERK) are two receptors that ... Of particular note in these antioxidant proteins is heme oxygenase 1 ([HO-1]), NAD(P)H-quinone oxidoreductase 1 (NQO1), and γ- ...
Kikuchi, G.; Yoshida, T.; Noguchi, M. (2005). "Heme oxygenase and heme degradation". Biochemical and Biophysical Research ... have caused the protein to have less of an affinity for inositol hexaphosphate (IHP), a molecule found in birds that has a ...

No FAQ available that match "inositol oxygenase"

No images available that match "inositol oxygenase"